Akili is Getting out of Prescription Digital Therapeutics
Akili executives said a focus on non-prescription digital therapies removes the barriers payers place on access and creates a more sustainable business.
Other Articles in this Edition
ADHD medications still in shortage, frustrating patients and doctors
Understanding the unique challenges of adult ADHD
ADHD Drug Shortages Worsen as Makers Say Production Is Maxed Out
Global review reveals ADHD rates in adults
Akili is Getting out of Prescription Digital Therapeutics
ADHD Research Roundup: September 8
Genes and environmental factors behind severe headache identified